FDA Inspection
University Of Texas MD Anderson Cancer Center: PETUniversity Of Texas MD Anderson Cancer Center: PET – FDA Inspection, Feb 24, 2026
Record Details
This FDA Inspection record concerns University Of Texas MD Anderson Cancer Center: PET, with an inspection on February 24, 2026, issued by the Dallas District Office, covering human drugs.
- Inspection Date
- February 24, 2026
- Product Type
- Human Drugs
View Company Profile
ID · a81dd300-c17b-4d66-a459-197cd0016a6f
Inspection Facts
- Inspection number
- 1301436
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 212.20(a)Oversight of production operations
- 21 CFR 212.30(a)Orderly handling, prevention of mix-ups, prevention of contamination
- 21 CFR 212.50Adequate controls (general)
- 21 CFR 212.50(c)(7)ID of major equipment
Full citation text and observation details available on the Dashboard.
Other FDA inspections of University Of Texas MD Anderson Cancer Center: PET
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 20, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 25, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 16, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for University Of Texas MD Anderson Cancer Center: PET
- FDA Inspection 1045262 - 2018-03-20
- FDA Inspection 981292 - 2016-07-25
- FDA Inspection 850187 - 2013-09-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.